Narrow search
Showing 1 - 2 of 2
Cover Image
Challenges to the Economic Evaluation of New Biotechnological Interventions in Healthcare
Mason, James - In: PharmacoEconomics 16 (1999) 2, pp. 119-125
The next century is likely to bring unforeseen genetic and biotechnological discoveries, with new benefits, risks and costs. This paper explores some of the problem areas that healthcare biotechnologies are likely to encounter. Biotechnological interventions may present particular difficulties...
Persistent link: https://www.econbiz.de/10005243140
Cover Image
Applying Epidemiology-Based Outcomes Research to Clinical Decision-Making: A Hypothetical Model of Biotechnology Therapy in Gram-Negative Sepsis
Wang, Edward C.Y.; Grasela, Thaddeus H.; Walawander, … - In: PharmacoEconomics 15 (1999) 4, pp. 385-393
Objective: Sepsis occurs in a heterogeneous population. A prospective nationwide surveillance study found that … populations stratified by infection type had significant differences in the incidence of sepsis syndrome, rate of complications … complications in sepsis syndrome. Healthcare resource utilisation data were based on length of hospital stay, intensive care unit …
Persistent link: https://www.econbiz.de/10004990322